Molecular insight into Proliferative Verrucous Leukoplakia: Are TERT promoter mutations a predictive marker?

Key Points

• TERT promoter mutations may serve as predictive markers for proliferative verrucous leukoplakia, indicating possible disease progression.
• Key evidence includes specific mutation rates associated with clinical outcomes, supporting the relevance of molecular profiling.
• Analysis involves identifying molecular insights through genetic sequencing and mutation evaluation in affected tissues.
• Findings suggest that TERT mutations could guide treatment strategies and patient monitoring in clinical settings.